Cosciens Biopharma Inc. logo

Cosciens Biopharma Inc. (CSCI)

Market Closed
10 Aug, 20:00
TSX TSX
CA$
7. 25
+0.2
+2.8369%
CA$
16.92M Market Cap
- P/E Ratio
- Div Yield
602 Volume
0 Eps
CA$ 7.05
Previous Close
Add Transaction
Day Range
7.06 7.25
Year Range
7 44.37
Want to track CSCI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Cosciens Biopharma Inc. (CSCI) Statistics

Valuation metrics

Market Cap 16.92M
Enterprise value 2.38M
Trailing P/E (ttm) -0.33
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 0.68
Price/Book (mrq) 0.12
Enterprise Value/Revenue 0.3
Enterprise Value/EBITDA -0.37

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 979
Average volume (90 days) 2.28K

Price summary

52-Week low 7
52-Week high 44.37
Beta -
50-Day moving average 7.15
200-Day moving average 3.65

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 50:150
Last split Date 3 Jul 2026

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.92%
Operating margin -0.96%

Operational effectiveness

Return on assets -0.39%
Return on equity -0.93%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 22.63
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -20.85
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 14.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 5.57%
Book value per share (mrq) 43.93

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -